Delivery Order SPE2DE24DA017-SPE2D626F464T
- Not listed
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $8,250.00 for the Arthrex ACP Double Syringe System on September 15, 2025. This fixed-price delivery order with economic price adjustment is scheduled for ultimate completion on September 18, 2025, and will be performed at the company's Naples, FL facility. The award was issued by the Defense Logistics Agency's Medical Supply Chain, a...
- Arthrex Inc., a Naples, Florida-based manufacturer of minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $10,393.29 for the Arthrex ACP Double Syringe System on December 10, 2025, with an ultimate completion date of December 15, 2025. This fixed-price delivery order with economic price adjustment falls under a larger single-award Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain, valued at $471 million...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,475 on August 6, 2025, for the Arthrex ACP Double Syringe System. This fixed-price delivery order with economic price adjustment is scheduled for completion by August 11, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain. The contract carries no...
- Arthrex Inc., a leading manufacturer of minimally invasive orthopedic medical devices based in Naples, Florida, was awarded a delivery order valued at $2,475.00 for the Arthrex ACP Double Syringe System, with an ultimate completion date of December 5, 2025. This fixed-price contract with economic price adjustment was issued without a set-aside designation and will be performed in Naples, Florida. The award is funded through the Defense Logistics Agency's Medical Supply Chain, which procures...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $2,475 fixed-price delivery order on August 8, 2025, for the Arthrex ACP Double Syringe System. The contract, issued by the Defense Logistics Agency's Medical Supply Chain, carries an ultimate completion date of August 13, 2025, and represents a non-set-aside award. This delivery order falls under the company's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense...
- Arthrex Inc., a leading manufacturer of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, received a delivery order valued at $4,950 for the Arthrex ACP Double Syringe System from the Defense Logistics Agency's Medical Supply Chain on November 7, 2025. The contract utilizes fixed-price pricing with economic price adjustment and carries an ultimate completion date of November 13, 2025. This award was issued without a set-aside designation, reflecting Arthrex's...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,475.00 on May 16, 2025, for the ARTHREX ACP Double Syringe System. This fixed-price contract with economic price adjustment provisions is scheduled for completion by May 21, 2025. The award carries no set-aside designation, reflecting Arthrex's strong competitive standing in the federal marketplace. The Medical Supply Chain, operating under the...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,665.20 for the Arthrex ACP Double Syringe System on April 24, 2025. This fixed-price contract with economic price adjustment carries an ultimate completion date of April 29, 2025, and will be performed in Naples, Florida. The award was issued by the Defense Logistics Agency's Medical Supply Chain to support the government's orthopedic medical device needs,...
- Arthrex Inc., headquartered in Naples, Florida, was awarded a delivery order valued at $1,650 on November 7, 2025, for the Arthrex ACP Double Syringe System. This fixed-price delivery order with economic price adjustment has an ultimate completion date of November 13, 2025, and will be performed at the contractor's Naples, Florida location. The award was made without a set-aside designation, reflecting Arthrex's strong competitive position in federal procurement. The contract is funded through...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $4,950 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on September 18, 2025, for the Arthrex ACP Double Syringe System. This delivery order, with an ultimate completion date of September 23, 2025, was awarded without a set-aside designation, reflecting Arthrex's strong competitive standing in the federal orthopedic medical device marketplace. The...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D626F464TDelivery Order
Arthrex Inc., a leading manufacturer of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $2,475.00 for the Arthrex ACP Double Syringe System on November 25, 2025, with a completion date of December 1, 2025. This fixed-price delivery order with economic price adjustment was issued without a set-aside designation and is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-oriented federal agency responsible for supplying orthopedic and surgical products to Department of Defense and Department of Veterans Affairs healthcare systems. The contract is being performed at Arthrex's facility in Naples, Florida. This delivery order operates under Arthrex's existing single-award Indefinite Delivery Contract SPE2DE24D0020 with the Defense Logistics Agency's Medical Supply Chain, a master contract valued at $471 billion and effective through September 1, 2029. The master contract authorizes procurement of a comprehensive spectrum of orthopedic surgical technologies, implants, and biologics to support military personnel and veteran healthcare across multiple surgical specialties. As a prime contractor, Arthrex fulfills federal requirements directly without subcontractors, leveraging its established competitive position and technical capabilities to deliver advanced orthopedic solutions to VA medical centers and Department of Defense healthcare facilities nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 11/24/25 |